{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T21:46:12Z","timestamp":1782510372700,"version":"3.54.5"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ucl.2026.03.002","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:24:43Z","timestamp":1779276283000},"page":"353-364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in Diagnosis of Non\u2013Muscle-Invasive Bladder Cancer"],"prefix":"10.1016","volume":"53","author":[{"given":"Michelle I.","family":"Higgins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Rivera Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soum D.","family":"Lokeshwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ucl.2026.03.002_bib1","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle Invasive Bladder Cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.002_bib2","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of urology (EAU) prognostic factor risk groups for non\u2013muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2026.03.002_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctarc.2021.100369","article-title":"Active surveillance for non-muscle invasive bladder cancer: a systematic review and pooled-analysis","volume":"27","author":"Petrelli","year":"2021","journal-title":"Cancer Treatment and Research Communications"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.002_bib4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/JU.0000000000004490","article-title":"Updates to microhematuria: AUA\/SUFU guideline (2025)","volume":"213","author":"Barocas","year":"2025","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.002_bib5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.002_bib6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.002_bib7","first-page":"1416","article-title":"Repeated transurethral resection for non-muscle invasive bladder cancer","volume":"8","author":"Cao","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.002_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.eururo.2017.03.019","article-title":"Curative treatment for muscle invasive bladder cancer in elderly patients: a systematic review","volume":"73","author":"Fonteyne","year":"2018","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ucl.2026.03.002_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/bju.16406","article-title":"Assessing long-term upgrade risks in recurrent low-grade non-muscle-invasive bladder cancer, can we deintensify the treatment?","volume":"134","author":"Finocchiaro","year":"2024","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.002_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.juro.2009.08.157","article-title":"Prospective validation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder","volume":"183","author":"Schlomer","year":"2010","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.002_bib11","first-page":"38","article-title":"Diagnostic value of urine cytology in bladder cancer. A meta-analysis","volume":"38","author":"Xie","year":"2016","journal-title":"Anal Quant Cytopathol Histpathol"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.002_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/PAP.0000000000000118","article-title":"The paris system for reporting urinary cytology: the quest to develop a standardized terminology","volume":"23","author":"Barkan","year":"2016","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"10.1016\/j.ucl.2026.03.002_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/cyt.12345","article-title":"A review of the paris system for reporting urinary cytology","volume":"27","author":"VandenBussche","year":"2016","journal-title":"Cytopathology"},{"issue":"2","key":"10.1016\/j.ucl.2026.03.002_bib14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/jpm12020170","article-title":"The paris system for reporting urinary cytology: a meta-analysis","volume":"12","author":"Nikas","year":"2022","journal-title":"J Personalized Med"},{"issue":"12","key":"10.1016\/j.ucl.2026.03.002_bib15","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00345-018-2380-x","article-title":"An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer","volume":"36","author":"Soria","year":"2018","journal-title":"World J Urol"},{"issue":"18","key":"10.1016\/j.ucl.2026.03.002_bib16","article-title":"Molecular markers for bladder cancer screening: an insight into bladder cancer and FDA-approved biomarkers","volume":"24","author":"Flores Monar","year":"2023","journal-title":"IJMS"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.002_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.urolonc.2020.08.016","article-title":"Urinary biomarkers in bladder cancer: a review of the current landscape and future directions","volume":"39","author":"Ng","year":"2021","journal-title":"Urol Oncol"},{"issue":"6 Suppl 1","key":"10.1016\/j.ucl.2026.03.002_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.urology.2005.08.064","article-title":"Bladder tumor markers beyond cytology: International consensus panel on bladder tumor markers","volume":"66","author":"Lokeshwar","year":"2005","journal-title":"Urology"},{"issue":"12","key":"10.1016\/j.ucl.2026.03.002_bib19","doi-asserted-by":"crossref","first-page":"922","DOI":"10.7326\/M15-0997","article-title":"Urinary biomarkers for diagnosis of bladder cancer: a systematic review and meta-analysis","volume":"163","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.002_bib20","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0022-5347(05)67104-2","article-title":"A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma","volume":"164","author":"Halling","year":"2000","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.002_bib21","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/S0022-5347(05)68934-3","article-title":"Immunocyt: a new tool for detecting transitional cell cancer of the urinary tract","volume":"161","author":"Mian","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2026.03.002_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.urology.2025.05.012","article-title":"Detection of high-grade bladder cancer in urine samples using in situ hybridization of long noncoding RNA UCA1","volume":"201","author":"Higgins","year":"2025","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ucl.2026.03.002_bib23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.juro.2017.09.141","article-title":"Development of a 90-Minute integrated noninvasive urinary assay for bladder cancer detection","volume":"199","author":"Wallace","year":"2018","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.002_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.euo.2020.09.001","article-title":"Validation of an mRNA-based urine test for the detection of bladder cancer in patients with haematuria","volume":"4","author":"van Valenberg","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.002_bib25","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.eururo.2018.11.055","article-title":"Prospective validation of an mRNA-based urine test for surveillance of patients with bladder cancer","volume":"75","author":"van Valenberg","year":"2019","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ucl.2026.03.002_bib26","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.juro.2016.12.010","article-title":"Performance characteristics of a multigene urine biomarker test for monitoring for recurrent urothelial carcinoma in a multicenter study","volume":"197","author":"Kavalieris","year":"2017","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.ucl.2026.03.002_bib27","doi-asserted-by":"crossref","first-page":"531.e15","DOI":"10.1016\/j.urolonc.2017.03.008","article-title":"Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma","volume":"35","author":"Lotan","year":"2017","journal-title":"Urol Oncol"},{"issue":"3 Pt 1","key":"10.1016\/j.ucl.2026.03.002_bib28","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.juro.2016.09.118","article-title":"Validation of a DNA methylation-mutation urine assay to select patients with hematuria for cystoscopy","volume":"197","author":"van Kessel","year":"2017","journal-title":"J Urol"},{"issue":"7407","key":"10.1016\/j.ucl.2026.03.002_bib29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nature11251","article-title":"Non-invasive prenatal measurement of the fetal genome","volume":"487","author":"Fan","year":"2012","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ucl.2026.03.002_bib30","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41585-023-00725-2","article-title":"Circulating and urinary tumour DNA in urothelial carcinoma \u2014 upper tract, lower tract and metastatic disease","volume":"20","author":"Rose","year":"2023","journal-title":"Nat Rev Urol"},{"issue":"30","key":"10.1016\/j.ucl.2026.03.002_bib31","doi-asserted-by":"crossref","first-page":"48832","DOI":"10.18632\/oncotarget.9453","article-title":"Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer","volume":"7","author":"Cheng","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ucl.2026.03.002_bib32","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK-25-471912","article-title":"Current and future role of circulating DNA in the diagnosis and management of urothelial carcinoma","volume":"45","author":"Bellmunt","year":"2025","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"8","key":"10.1016\/j.ucl.2026.03.002_bib33","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1158\/1078-0432.CCR-22-3250","article-title":"Cell-free urine and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle-invasive bladder cancer","volume":"29","author":"Christensen","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"15","key":"10.1016\/j.ucl.2026.03.002_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512489","article-title":"Bladder epicheck test: a novel tool to support urothelial carcinoma diagnosis in urine samples","volume":"24","author":"Fiorentino","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.002_bib35","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1016\/j.clgc.2022.03.009","article-title":"The role of bladder epicheck test in Follow-Up of patients with non-muscle invasive bladder cancer","volume":"20","author":"Ragonese","year":"2022","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.002_bib36","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/23523735241304348","article-title":"North American study and meta-analysis evaluating performance of bladder EpiCheck\u00ae, a FDA cleared test, in non-muscle invasive bladder cancer recurrence","volume":"10","author":"Fleshner","year":"2024","journal-title":"Bladder Cancer"},{"issue":"3","key":"10.1016\/j.ucl.2026.03.002_bib37","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/01.ju.0000169424.79702.6d","article-title":"Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor","volume":"174","author":"Palou","year":"2005","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.002_bib38","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0022-5347(05)67137-6","article-title":"Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups","volume":"164","author":"An-Rodriguez","year":"2000","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ucl.2026.03.002_bib39","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.eururo.2015.01.032","article-title":"Prognostic and prediction tools in bladder cancer: a comprehensive review of the literature","volume":"68","author":"Kluth","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2026.03.002_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2024\/5894288","article-title":"Routine surveillance of upper urinary tract imaging for diagnosing upper urinary tract urothelial cancer recurrence in patients with nonmuscle invasive bladder cancer","volume":"2024","author":"Nishimura","year":"2024","journal-title":"Adv Urol"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.002_bib41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12957-022-02664-5","article-title":"Distant metastasis without regional progression in non-muscle invasive bladder cancer: case report and pooled analysis of literature","volume":"20","author":"Xu","year":"2022","journal-title":"World J Surg Onc"},{"issue":"2","key":"10.1016\/j.ucl.2026.03.002_bib42","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.juro.2015.12.093","article-title":"Assessing cancer risk on novel 29 MHz micro-ultrasound images of the prostate: creation of the micro-ultrasound protocol for prostate risk identification","volume":"196","author":"Ghai","year":"2016","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.ucl.2026.03.002_bib43","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.eururo.2019.03.044","article-title":"Assessing the feasibility and accuracy of high-resolution microultrasound imaging for bladder cancer detection and staging","volume":"77","author":"Saita","year":"2020","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ucl.2026.03.002_bib44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/BLC-211611","article-title":"Head-to-Head comparison between high-resolution microultrasound imaging and multiparametric MRI in detecting and local staging of bladder cancer: the BUS-MISS protocol","volume":"8","author":"Diana","year":"2022","journal-title":"Bladder Cancer"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.002_bib45","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221263","article-title":"Patient exposure from radiologic and nuclear medicine procedures in the United States and worldwide: 2009\u20132018","volume":"307","author":"Mahesh","year":"2023","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.002_bib46","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.3390\/tomography9050138","article-title":"Systematic evaluation of imaging features of early bladder cancer using computed tomography performed before pathologic diagnosis","volume":"9","author":"Malik","year":"2023","journal-title":"Tomography"},{"issue":"2","key":"10.1016\/j.ucl.2026.03.002_bib47","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00330-015-3844-7","article-title":"Comparison of post contrast CT urography phases in bladder cancer detection","volume":"26","author":"Helenius","year":"2016","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.002_bib48","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1053\/j.semnuclmed.2021.12.004","article-title":"PET\/CT in bladder cancer: an update","volume":"52","author":"Bouchelouche","year":"2022","journal-title":"Semin Nucl Med"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.002_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s43046-023-00180-5","article-title":"Fluorodeoxyglucose positron emission tomography (18F-FDG PET)-computed tomography (CT) in the initial staging of bladder cancer: a single institution experience","volume":"35","author":"Shahait","year":"2023","journal-title":"J Egypt Natl Canc Inst"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.002_bib50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/tomography9010003","article-title":"Feasibility of early evaluation for the recurrence of bladder cancer after trans-urethral resection: a comparison between magnetic resonance imaging and multidetector computed tomography","volume":"9","author":"Wang","year":"2022","journal-title":"Tomography"},{"issue":"12","key":"10.1016\/j.ucl.2026.03.002_bib51","first-page":"1417","article-title":"Randomized comparison of magnetic resonance imaging versus transurethral resection for staging new bladder cancers: results from the prospective BladderPath trial","volume":"43","author":"Bryan","year":"2025","journal-title":"J Clin Orthod"},{"issue":"3","key":"10.1016\/j.ucl.2026.03.002_bib52","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","article-title":"Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (vesical imaging-reporting and data system)","volume":"74","author":"Panebianco","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2026.03.002_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2024.111868","article-title":"VI steps to achieve VI-RADS assessment","volume":"183","author":"Srisajjakul","year":"2025","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.002_bib54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eururo.2019.09.029","article-title":"Prospective assessment of vesical imaging reporting and data system (VI-RADS) and its clinical impact on the management of high-risk non-muscle-invasive bladder cancer patients candidate for repeated transurethral resection","volume":"77","author":"Del Giudice","year":"2020","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ucl.2026.03.002_bib55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.urolonc.2021.11.008","article-title":"Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) in suspected muscle invasive bladder cancer: a systematic review and diagnostic meta-analysis","volume":"40","author":"Jazayeri","year":"2022","journal-title":"Urol Oncol: Seminars and Original Investigations"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.002_bib56","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/ph16040606","article-title":"PET imaging in bladder cancer: an update and future direction","volume":"16","author":"Zhang-Yin","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"4 Pt 1","key":"10.1016\/j.ucl.2026.03.002_bib57","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.juro.2006.06.085","article-title":"Max nitze, the cystoscope and urology","volume":"176","author":"Herr","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2026.03.002_bib58","first-page":"221","article-title":"Market readiness for single-use cystoscopes according to urologists and procurement managers worldwide","volume":"13","author":"Rindorf","year":"2021","journal-title":"Res Rep Urol"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.002_bib59","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/bju.15949","article-title":"Environmental impact of single-use and reusable flexible cystoscopes","volume":"131","author":"Kemble","year":"2023","journal-title":"BJU Int"},{"issue":"12","key":"10.1016\/j.ucl.2026.03.002_bib60","doi-asserted-by":"crossref","first-page":"8136","DOI":"10.1097\/JS9.0000000000002141","article-title":"Beyond single-use: a systematic review of environmental, economic, and clinical impacts of endoscopic surgical instrumentation","volume":"110","author":"Eussen","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.ucl.2026.03.002_bib61","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.urology.2024.03.023","article-title":"Institutional micro-cost comparative analysis of reusable vs single-use cystoscopes with assessment of environmental footprint","volume":"188","author":"Bertolo","year":"2024","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2026.03.002_bib62","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.urology.2022.05.039","article-title":"Cost-effectiveness of 90-day single-use flexible cystoscope trial: single center micro-costing analysis and user satisfaction","volume":"167","author":"Assmus","year":"2022","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.002_bib63","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00345-025-05705-2","article-title":"Reusable vs. single use cystoscope: economic & environmental assessment","volume":"43","author":"Ait Taleb","year":"2025","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.002_bib64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.ju.0000100480.70769.0e","article-title":"Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy","volume":"171","author":"Schmidbauer","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2026.03.002_bib65","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.urology.2019.12.002","article-title":"DaBlaCa-11: photodynamic diagnosis in flexible Cystoscopy-A randomized study with focus on recurrence","volume":"137","author":"Drejer","year":"2020","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.002_bib66","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.juro.2017.11.096","article-title":"Efficacy and safety of blue light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: a phase III, comparative, multicenter study","volume":"199","author":"Daneshmand","year":"2018","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.ucl.2026.03.002_bib67","doi-asserted-by":"crossref","first-page":"382.e1","DOI":"10.1016\/j.urolonc.2022.04.012","article-title":"Safety of repeat blue light cystoscopy with hexaminolevulinate (HAL) in the management of bladder cancer: results from a phase III, comparative, multi-center study","volume":"40","author":"Pohar","year":"2022","journal-title":"Urol Oncol"},{"issue":"10","key":"10.1016\/j.ucl.2026.03.002_bib68","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200092","article-title":"A randomized trial of PHOTOdynamic surgery in non-muscle-invasive bladder cancer","volume":"1","author":"Heer","year":"2022","journal-title":"NEJM Evid"},{"issue":"11 Pt B","key":"10.1016\/j.ucl.2026.03.002_bib69","first-page":"E680","article-title":"Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis","volume":"110","author":"Zheng","year":"2012","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.ucl.2026.03.002_bib70","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.eururo.2016.03.053","volume":"70","author":"Naito","year":"2016","journal-title":"Eur Urol"},{"issue":"14","key":"10.1016\/j.ucl.2026.03.002_bib71","doi-asserted-by":"crossref","first-page":"23880","DOI":"10.18632\/oncotarget.13054","article-title":"Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: a systematic review and meta-analysis","volume":"8","author":"Kang","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.002_bib72","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.juro.2009.06.039","article-title":"Optical biopsy of human bladder neoplasia with in vivo confocal laser endomicroscopy","volume":"182","author":"Sonn","year":"2009","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.002_bib73","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1245\/s10434-019-07200-6","article-title":"Probe-based confocal laser endomicroscopy during transurethral resection of bladder tumors improves the diagnostic accuracy and therapeutic efficacy","volume":"26","author":"Lee","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ucl.2026.03.002_bib74","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.euros.2024.11.007","article-title":"Prospective analysis of confocal laser endomicroscopy for assessment of the resection bed for bladder tumor","volume":"71","author":"de Ruiter","year":"2025","journal-title":"Eur Urol Open Sci"},{"issue":"2","key":"10.1016\/j.ucl.2026.03.002_bib75","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/jnci\/djab179","article-title":"An artificial intelligence system for the detection of bladder cancer via cystoscopy: a multicenter diagnostic study","volume":"114","author":"Wu","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ucl.2026.03.002_bib76","doi-asserted-by":"crossref","DOI":"10.1089\/end.2023.0056","article-title":"Real-time detection of bladder cancer using augmented cystoscopy with deep learning: a pilot study","author":"Chang","year":"2023","journal-title":"J Endourol"},{"issue":"13","key":"10.1016\/j.ucl.2026.03.002_bib77","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.3390\/cancers17132070","article-title":"Novel strategies and therapeutic advances for bladder cancer","volume":"17","author":"Ehrlich","year":"2025","journal-title":"Cancers (Basel)"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014326000285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014326000285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:55:51Z","timestamp":1782507351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014326000285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0094014326000285"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2026.03.002","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Diagnosis of Non\u2013Muscle-Invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2026.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}